Breast Cancer Biomarkers as a Clinical Management Tool  front page preview

Breast Cancer Biomarkers as a Clinical Management Tool

The global market for ER-positive breast cancer is estimated to be 2.86 billion. Despite availability of effective treatments, survival rates are low in Stage IV as compared to other stages. ADAM22 is a novel therapeutic...

pdf 437.5KB

Labeling and Detection Method for Endogenous Exosome  front page preview

Labeling and Detection Method for Endogenous Exosome

The growing commercial interest in exosomes as diagnostics and therapeutics has given rise to an urgent need for an efficient labelling and detection method that does not alter their inherent characteristics. RCSI has de...

pdf 422.9KB

miRaColl - A Collagen-Based Scaffold for Cartilage Repair  front page preview

miRaColl - A Collagen-Based Scaffold for Cartilage Repair

miRaColl is a novel, miRNA-eluting collagen-based scaffold with applications in regenerative medicine. A proprietary process developed at RCSI enables the production of reliable, shelf-stable, biocompatible scaffolds con...

pdf 401.6KB

Star Polypeptides A New Class of Polymer front page preview

Star Polypeptides A New Class of Polymer

Star-polymers are a new class of polymer architecture which consist of linear arms radiating from a central core. Novel Star-polypeptides discovered at RCSI have been demonstrated to have superior transfection and delive...

pdf 580.9KB

Engineered Materials from Recycled Plastics  front page preview

Engineered Materials from Recycled Plastics

Researchers from the Irish Composites Centre in UL (IComp) have developed a new, technology to repurpose recycled or virgin plastic (e.g. PET) into a self-reinforced polymer composite material suitable for a range of new...

pdf 179.2KB